Two-year prospective study of major depressive disorder in HIV-infected men

J. Hampton Atkinson, Robert K. Heaton, Thomas L. Patterson, Tanya Wolfson, Reena Deutsch, Stephen J. Brown, J. Summers, Andres F Sciolla, R. Gutierrez, Ronald J. Ellis, Ian Abramson, John R. Hesselink, J. Allen McCutchan, Igor Grant

Research output: Contribution to journalArticle

75 Scopus citations

Abstract

Objective: The risks and factors contributing to major depressive episodes in HIV infection remain unclear. This 2-year prospective study compared cumulative rates and predictors of a major depressive episode in HIV-infected (HIV+) men (N = 297) and uninfected (HIV-) risk-group controls (N = 90). Methods: By design participants at entry were without current major depression, substance dependence or major anxiety disorder. Standardized neuromedical, neuropsychological, neuroimaging, life events, and psychiatric assessments (Structured Clinical Interview for DSM III-R) were conducted semi-annually for those with AIDS, and annually for all others. Results: Lifetime prevalence of major depression or other psychiatric disorder did not differ at baseline between HIV+ men and controls. On a two-year follow-up those with symptomatic HIV disease were significantly more likely to experience a major depressive episode than were asymptomatic HIV+ individuals and HIV-controls (p < 0.05). Episodes were as likely to be first onset as recurrent depression. After baseline disease stage and medical variables associated with HIV infection were controlled, a lifetime history of major depression, or of lifetime psychiatric comorbidity (two or more psychiatric disorders), predicted subsequent major depressive episode (p < 0.05). Neither HIV disease progression during follow-up, nor the baseline presence of neurocognitive impairment, clinical brain imaging abnormality, or marked life adversity predicted a later major depressive episode. Limitations: Research cohort of men examined before era of widespread use of advanced anti-HIV therapies. Conclusions: Symptomatic HIV disease, but not HIV infection itself, increases intermediate-term risk of major depression. Prior psychiatric history most strongly predicted future vulnerability.

Original languageEnglish (US)
Pages (from-to)225-234
Number of pages10
JournalJournal of Affective Disorders
Volume108
Issue number3
DOIs
StatePublished - Jun 2008

Keywords

  • AIDS
  • Human immunodeficiency virus
  • Major depression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Fingerprint Dive into the research topics of 'Two-year prospective study of major depressive disorder in HIV-infected men'. Together they form a unique fingerprint.

  • Cite this

    Atkinson, J. H., Heaton, R. K., Patterson, T. L., Wolfson, T., Deutsch, R., Brown, S. J., Summers, J., Sciolla, A. F., Gutierrez, R., Ellis, R. J., Abramson, I., Hesselink, J. R., McCutchan, J. A., & Grant, I. (2008). Two-year prospective study of major depressive disorder in HIV-infected men. Journal of Affective Disorders, 108(3), 225-234. https://doi.org/10.1016/j.jad.2007.10.017